Clinical Trial

Early Infant HIV Treatment in Botswana

Study acronym: EIT
Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
The overall objective of this study is to determine whether very early antiretroviral treatment (ART) initiation in HIV-infected infants limits the seeding of viral reservoirs and maintains immune responses, potentially allowing future periods off ART.
Protocol Amendment History 11 amendments
This ClinicalTrials.gov record has been amended 11 times since 2015-02-21; most recent amendment 2026-02-20.
Status change: Recruiting → Active, Not Recruiting 2021-05-12
Status change: Not Yet Recruiting → Recruiting 2015-04-27
Trial Details
NCT Number NCT02369406
Lead Sponsor Harvard School of Public Health (HSPH)
Collaborators: Ragon Institute of MGH, MIT and Harvard, Brigham and Women's Hospital, Botswana Harvard Health Partnership, University of California, San Diego
Conditions HIV, Pediatric AIDS
Enrollment 67 participants
Start Date 2015-05-04
Primary Completion 2020-11-06 (estimated)
Study Completion 2029-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-23